Stay updated on Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.

Latest updates to the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check36 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check65 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check79 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.15.0) and a future date (2025-04-09), replacing the previous revision (v2.14.4) and date (2025-01-14).SummaryDifference2%
- Check87 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date of 2025-03-25 while adding a new date of 2025-01-14.SummaryDifference1.0%
Stay in the know with updates to Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.